Levalbuterol lowers the feedback inhibition by dopamine and delays misfolding and aggregation in tyrosine hydroxylase

Beta 2 agonists and the incidence of Parkinson’s disease

(2020) Francesco Giorgianni et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

β-adrenoreceptors and the risk of Parkinson's disease

(2020) Franziska Hopfner et al.   LANCET NEUROLOGY

Circular Dichroism Spectroscopy Identifies the β-Adrenoceptor Agonist Salbutamol As a Direct Inhibitor of Tau Filament Formation in Vitro

(2020) David J Townsend et al.   ACS Chemical Neuroscience

Beta2-Adrenoceptor Agonists in Parkinson’s Disease and Other Synucleinopathies

(2019) Luca Magistrelli et al.   Journal of Neuroimmune Pharmacology

Isothermal Analysis of ThermoFluor Data can readily provide Quantitative Binding Affinities

(2019) Nan Bai et al.   Scientific Reports

Tyrosine hydroxylase phosphorylation in vivo

(2019) Peter R. Dunkley et al.   JOURNAL OF NEUROCHEMISTRY

Targeted repositioning identifies drugs that increase fibroblast growth factor 20 production and protect against 6-hydroxydopamine-induced nigral cell loss in rats

(2019) Edward J. R. Fletcher et al.   Scientific Reports

Cost Effectiveness of Pharmacological Treatments for Asthma: A Systematic Review

(2018) Carlos E. Rodriguez-Martinez et al.   PHARMACOECONOMICS

Selective neuronal vulnerability in Parkinson disease

(2017) D. James Surmeier et al.   NATURE REVIEWS NEUROSCIENCE

β2-Adrenoreceptor is a regulator of the α-synuclein gene driving risk of Parkinson’s disease

(2017) Shuchi Mittal et al.   SCIENCE

Stable preparations of tyrosine hydroxylase provide the solution structure of the full-length enzyme

(2016) Maria T. Bezem et al.   Scientific Reports

Tyrosine Hydroxylase Binding to Phospholipid Membranes Prompts Its Amyloid Aggregation and Compromises Bilayer Integrity

(2016) Anne Baumann et al.   Scientific Reports

Discovery of compounds that protect tyrosine hydroxylase activity through different mechanisms

(2015) Magnus Hole et al.   BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS

Brain catecholamine depletion and motor impairment in aThknock-in mouse with type B tyrosine hydroxylase deficiency

(2015) Germaine Korner et al.   BRAIN

Structural insights into the regulation of aromatic amino acid hydroxylation

(2015) Paul F Fitzpatrick   CURRENT OPINION IN STRUCTURAL BIOLOGY

Functional Studies of Tyrosine Hydroxylase Missense Variants Reveal Distinct Patterns of Molecular Defects in Dopa-Responsive Dystonia

(2014) Agnete Fossbakk et al.   HUMAN MUTATION

Levodopa-induced dyskinesias in tyrosine hydroxylase deficiency

(2013) Roser Pons et al.   MOVEMENT DISORDERS

A Synopsis on the Role of Tyrosine Hydroxylase in Parkinson’s Disease

(2012) Shams Tabrez et al.   CNS & Neurological Disorders-Drug Targets

Tyrosine hydroxylase and regulation of dopamine synthesis

(2010) S. Colette Daubner et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis

(2010) M. A. Willemsen et al.   BRAIN